167 related articles for article (PubMed ID: 22729192)
1. YMDD motif mutations in chronic hepatitis B antiviral treatment naïve patients: a multi-center study.
Tan YW; Ge GH; Zhao W; Gan JH; Zhao Y; Niu ZL; Zhang DJ; Chen L; Yu XJ; Yang LJ
Braz J Infect Dis; 2012; 16(3):250-5. PubMed ID: 22729192
[TBL] [Abstract][Full Text] [Related]
2. Natural YMDD-motif mutants affect clinical course of lamivudine in chronic hepatitis B.
Tan YW; Ye Y; Ge GH; Zhao W; Gan JH; Zhao Y; Niu ZL; Zhang DJ; Chen L; Yu XJ; Yang LJ
World J Gastroenterol; 2015 Feb; 21(7):2089-95. PubMed ID: 25717242
[TBL] [Abstract][Full Text] [Related]
3. [YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].
Arslan U; Ural O; Findik D
Mikrobiyol Bul; 2008 Jul; 42(3):445-50. PubMed ID: 18822888
[TBL] [Abstract][Full Text] [Related]
4. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.
Akarsu M; Sengonul A; Tankurt E; Sayiner AA; Topalak O; Akpinar H; Abacioglu YH
J Gastroenterol Hepatol; 2006 Dec; 21(12):1783-8. PubMed ID: 17074014
[TBL] [Abstract][Full Text] [Related]
5. [A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].
Ağca H; Sayıner AA; Sengönül A; Simşek I; Akarsu M
Mikrobiyol Bul; 2011 Oct; 45(4):664-76. PubMed ID: 22090297
[TBL] [Abstract][Full Text] [Related]
6. Prevelance of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population.
Alagozlu H; Ozdemir O; Koksal B; Yilmaz A; Coskun M
Asian Pac J Cancer Prev; 2013; 14(9):5489-94. PubMed ID: 24175847
[TBL] [Abstract][Full Text] [Related]
7. Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment.
Wu F; Wu MJ; Zhuge XL; Zhu SM; Zhu B
Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):172-6. PubMed ID: 22484586
[TBL] [Abstract][Full Text] [Related]
8. YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.
Huang ZM; Huang QW; Qin YQ; He YZ; Qin HJ; Zhou YN; Xu X; Huang MJ
World J Gastroenterol; 2005 Feb; 11(6):867-70. PubMed ID: 15682483
[TBL] [Abstract][Full Text] [Related]
9. Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants.
Jardi R; Buti M; Rodriguez-Frias F; Cotrina M; Costa X; Pascual C; Esteban R; Guardia J
J Virol Methods; 1999 Dec; 83(1-2):181-7. PubMed ID: 10598095
[TBL] [Abstract][Full Text] [Related]
10. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
Paik YH; Han KH; Hong SP; Lee HW; Lee KS; Kim SO; Shin JE; Ahn SH; Chon CY; Moon YM
Antivir Ther; 2006; 11(4):447-55. PubMed ID: 16856618
[TBL] [Abstract][Full Text] [Related]
11. The naturally occurring YMDD mutation among patients chronically infected HBV and untreated with lamivudine: a systematic review and meta-analysis.
Tan Y; Ding K; Su J; Trinh X; Peng Z; Gong Y; Chen L; Cui Q; Lei N; Chen X; Yu R
PLoS One; 2012; 7(3):e32789. PubMed ID: 22479339
[TBL] [Abstract][Full Text] [Related]
12. A novel accurate ACRS-PCR method with a digestion internal control for identification of wild type and YMDD mutants of hepatitis B virus strains.
Hosseini SY; Sabahi F; Amini-Bavil-Olyaee S; Alavian SM; Merat S
J Virol Methods; 2006 Nov; 137(2):298-303. PubMed ID: 16962669
[TBL] [Abstract][Full Text] [Related]
13. Lamivudine and Adefovir Motif Variants Detected in chronic Hepatıtıs B patients.
Ozekinci T; Mese S; Ozbek E; Atmaca S
Clin Ter; 2014; 165(1):13-7. PubMed ID: 24589944
[TBL] [Abstract][Full Text] [Related]
14. Quantitative subtyping of hepatitis B virus reveals complex dynamics of YMDD motif mutants development during long-term lamivudine therapy.
Ding C; Wong VW; Chow KC; Chan HY; Hui AY; Wong GL; Lo YM; Sung JJ; Chan HL
Antivir Ther; 2006; 11(8):1041-9. PubMed ID: 17302374
[TBL] [Abstract][Full Text] [Related]
15. PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine.
Yang DH; Liang WF; Xie YJ; Zhao NF; Fan J
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):232-7. PubMed ID: 14612274
[TBL] [Abstract][Full Text] [Related]
16. Pre-existing YMDD mutants in treatment-naïve patients with chronic hepatitis B are not selected during lamivudine therapy.
Lee SH; Kim HS; Byun IS; Jeong SW; Kim SG; Jang JY; Kim YS; Kim BS
J Med Virol; 2012 Feb; 84(2):217-22. PubMed ID: 22170540
[TBL] [Abstract][Full Text] [Related]
17. [Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].
Cao XX; Li J; Qiu LM; Luo YW; Chen YH; Ran Y
Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):641-4. PubMed ID: 19785947
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].
Deng H; Lv Y; Fu J
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):368-9. PubMed ID: 15225437
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and distribution of hepatitis B virus genotypes in Guangxi Zhuang population.
Huang ZM; Huang QW; Qin YQ; Huang CH; Qin HJ; Zhou YN; Xu X; Lu CL
World J Gastroenterol; 2005 Nov; 11(41):6525-9. PubMed ID: 16425428
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.
Yuen MF; Sablon E; Hui CK; Yuan HJ; Decraemer H; Lai CL
Hepatology; 2001 Oct; 34(4 Pt 1):785-91. PubMed ID: 11584376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
